Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial (Q34585310)
scientific article
Language:
Current Data About Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial
(P31) (Q13442814)
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

(P50) (Q37374325)
(P1932) Carolyn A Young
(P1545) 3

(P304) 2068-2079
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

(P433) 9
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

(P478) 29
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

(P577) Saturday, September 1, 2007
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

(P921) (Q2798704)

(Q8277)

(Q422917)

(Q190067)

(Q422936)

(P1433) (Q15716601)
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

(P1476) "Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial" (language: en)
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

(P2093) David J Rog
(P1545) 1
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

Turo J Nurmikko
(P1545) 2
(P248)
(P698) 18035205
(P813) Thursday, August 3, 2017

other details
description scientific article

External Links
(P356) 10.1016/J.CLINTHERA.2007.09.013
(P698) 18035205
(P5875) 5812845